Cardiovascular Therapies and Risk for Development of Diabetes
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (3) , 509-512
- https://doi.org/10.1016/j.jacc.2004.03.071
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Adverse Prognostic Significance of New Diabetes in Treated Hypertensive SubjectsHypertension, 2004
- The Study on Cognition and Prognosis in the Elderly (SCOPE)Journal Of Hypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDMDiabetes Care, 1998
- The Swedish Trial in Old Patients with Hypertension-2 (STOP-Hypertension-2): A Progress ReportBlood Pressure, 1996
- Metabolic effects of antihypertensive drugsJournal Of Hypertension, 1995
- Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trialsBlood Pressure, 1992
- Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groupsJournal Of Hypertension, 1989
- Propranolol or hydrochlorothiazide alone for the initial treatment of hypertension. IV. Effect on plasma glucose and glucose tolerance. Veterans Administration Cooperative Study Group on Antihypertensive Agents.Hypertension, 1985
- EFFECT OF DIURETIC THERAPY ON GLUCOSE TOLERANCE IN HYPERTENSIVE PATIENTSThe Lancet, 1971